Eicosanoid inhibitors enhance synergistically the effect of transforming growth factor β1 on CCL 64 cell proliferation

European Journal of Pharmacology

Volumn 316, Issue 2-3, 1996, Pages 349-357

  Kozubík, Alois ^a   Hofmanová, Jiřina ^a   Dušek, Ladislav ^b  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Arachidonic acid; Cell cycle; Cell proliferation; Epithelial cells; TGF 1 (transforming growth factor 1)

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ESCULETIN; ICOSATETRAYNOIC ACID; INDOMETACIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL COUNT; CELL CYCLE; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; FLOW CYTOMETRY; LUNG ALVEOLUS CELL; MINK; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACID; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSANOIDS; EPITHELIUM; LUNG; MINK; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030571496     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00691-7     Document Type: Article

References (38)

1. Ahuja, S.S., F. Paliogianni, H. Yamada, J.E. Balow and D.T. Boumpas, 1993, Effect of transforming growth factor-β on early and late activation events in human T cells, J. Immunol. 150, 3109.
2. Anderson, V.L. and R.A. McLean, 1974, Design of Experiments, A Realistic Approach (Marcel Dekker, New York, NY).
3. Anderson, K.M., F. Ondrey and J.E. Harris, 1989. Arachidonic acid analogues: An additional class of membrane active agents with potential anticancer activity, Prostaglandins Leukotrienes Essent. Fatty Acids 35, 231.
4. Attisano, L., J.L. Wrana, F. López-Casillas and J. Massagué, 1994, TGF-β receptors and actions, Biochim. Biophys. Acta 1222, 71.
5. Bandyopadhyay, G.K., S.I. Hwang, W. Imagawa and S. Nandi, 1993, Role of polyunsaturated fatty acids as signal transducers: Amplification of signals from growth factor receptors by fatty acids in mammary epithelial cells, Prostaglandins Leukotrienes Essent. Fatty Acids 48, 71.
6. Barnard, J.A., R.M. Lyons and H.L. Moses, 1990, The cell biology of transforming growth factor β. Biochim. Biophys. Acta 1032, 79.
7. Berenbaum, M.C., 1981, Criteria for analyzing interactions between biologically active agents. Adv. Cancer Res. 35, 269.
8. Clarke, S.D. and D.B. Jump, 1994, Dietary polyunsaturated fatty acid regulation of gene transcription. Annu. Rev. Nutr. 14, 83.
9. Dokter, W.H.A., S.J. Sierdsema, M.T. Esselink, M.R. Halie and E. Vellenga, 1994, Interleukin-4-mediated inhibition of c-fos mRNA expression: Role of the lipoxygenase directed pathway, Leukemia 8, 1181.
10. Finstad, H.S., S.O. Kolset, J.A. Holme, R. Wiger, A.K.O. Farrants, R. Blomhoff and Ch.A. Drevon, 1994, Effect of n-3 and n-6 fatty acids on proliferation and differentiation of promyelocytic leukemic HL-60 cells, Blood 84, 3799.
11. Garrigue-Antar, L., I. Barbieux, B. Lieubeau, O. Boisteau and M. Grégoire, Optimisation of CCL64-based bioassay for TGF-β, 1995, J. Immunol. Methods 186, 267.
12. 1 cyclins and cyclin-dependent protein kinases, Proc. Natl. Acad. Sci. USA 90, 10315.
13. Johnson, T.C., 1994, Negative regulators of cell proliferation, Pharmacol. Ther. 62, 247.
14. Ko, T.C., H.M. Sheng, D. Reisman, E.A. Thompson and R.D. Beauchamp, 1995, Transforming growth factor-β1 inhibits cyclin D1 expression in intestinal epithelial cells, Oncogene 10, 177.
15. Kozubík, A., J. Hofmanová, J. Holá, and J. Netíková, 1993, The effect of nordihydroguaiaretic acid an inhibitor of prostaglandin and leukotriene biosynthesis, on hematopoiesis of gamma-irradiated mice. Exp. Hematol. 21, 138.
16. Kozubík, A., J. Hofmanová, M. Pospíšil, J. Netíková, J. Holá and A. Lojek, 1994. Effects of drugs inhibiting prostaglandin or leukotriene biosynthesis on postirradiation haematopoiesis in mouse, Int. J. Radiat. Biol. 65, 369.
17. Lin, H.Y., X.F. Wang, E. Ng-Eaton, R.A. Weinberg and H.F. Lodish, 1992, Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase, Cell 68, 775.
18. Liu, M.A. and A. Oliff, 1991, Transforming growth factor-β-mullerian inhibiting substance family of growth regulators. Cancer Invest. 9, 325.
19. Masongarcia, M., S. Clejan, J.S. Tou and B.S. Beckman, 1992, Signal transduction by the erythropoietin receptor evidence for the activation of phospholipases A2 and C, Am. J. Physiol. 262, C1197.
20. Mazars, P., N. Barboule, V. Baldin, S. Vidal, B. Ducommun and A. Valette, 1995, Effects of TGF-β1 (transforming growth factor-β1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells, FEBS Lett. 362, 295.
21. 4 as essential intermediates in CSF-stimulated human myeloid colony formation, Exp. Hematol. 14, 760.
22. Miller, A.M., E. Sandler, S.M. Kobb, J. Eastgate and J. Zucali, 1993, Hematopoietic growth factor induction of gamma-glutamyl transferase in the KG-I myeloid cell Line, Exp. Hematol. 21, 9.
23. Naor, Z., 1991, Is arachidonic acid a second messenger in signal transduction?, Mol. Cell. Endocrinol. 80, C181.
24. Neichi, T., Y. Koshihara and S.-I. Murota, 1983. Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis, Biochim. Biophys. Acta 753, 130.
25. Newman, M.J., 1990, Inhibition of carcinoma and melanoma cell growth by type 1 transforming growth factor β is dependent on the presence of polyunsaturated fatty acids, Proc. Natl. Acad. Sci. USA 87, 5543.
26. 4 production, Cell 69, 295.
27. Roberts, A.B. and M.B. Sporn, 1988, Transforming growth factor β, Adv. Cancer Res. 51, 107.
28. Roberts, A.B., N.L. Thompson, U. Heine, C. Flanders and M.B. Sporn, 1988, Transforming growth factor-β: possible roles in carcinogenesis, Br. J. Cancer 57, 594.
29. Roberts, A.B., K.C. Flanders, U.I. Heine, S. Jakowlew, P. Kondaiah, S.J. Kim and M.B. Sporn, 1990, Transforming growth factor-β: multifunctional regulator of differentiation and development, Philos. Trans. R. Soc. London B 327, 145.
30. Rouzer, C.A., A.W. Ford-Hutchinson, H.E. Morton and J.W. Gillard, 1990, MK886, a potent and specific leukotriene biosynthesis inhibitor, blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes, J. Biol. Chem. 265, 1436.
31. Snyder, D.S., R. Castro and J.F. Desforges, 1989, Antiproliferative effects of lipoxygenase inhibitors on malignant human hematopoietic cell lines, Exp. Hematol. 17, 6.
32. Sumida, C., R. Graber and E. Nunez, 1993, Role of fatty acids in signal transduction: Modulators and messengers, Prostaglandins Leukotrienes Essent. Fatty Acids 48, 117.
33. Taylor, A.S., A.R. Morrison and J.H. Russell, 1985, Incorporation of 5, 8, 11, 14-eicosatetraynoic acid (eicosatetraynoic acid) into cell lipids: competition with arachidonic acid for esterification, Prostaglandins 29, 449.
34. Teatle, R., C. Payne, B.D. Santos, M. Russell and P. Segarini, 1993, Effects of transforming growth factor β1 on growth and apoptosis of human acute myelogenous leukemia cells, Cancer Res. 53, 3386.
35. Tobias, L.D. and J.C. Hamilton, 1979, The effect of 5, 8, 11,14-eicosatetraynoic acid on lipid metabolism, Lipids 14, 181.
36. Vindelov, L.L., 1977, Microfluorometric analysis of nuclear DNA in cells from tumors and cell suspension, Virchows Arch. Cell. Pathol. 24, 227.
37. Yan, Z., S. Winawer and E. Friedman, 1994, Two different signal transduction pathways can be activated by transforming growth factor β1 in epithelial cells, J. Biol. Chem. 269, 13231.
38. Zar, J.H., 1974, Biostatistical analysis (Prentice-Hall, NJ).